DNTH
DNTH
US2528281080
Dianthus Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.036.000 6.235.000
67.3%
Cost of Revenue -- --
--
Gross Profit -- --
--
179.969.000 108.099.000
66.5%
Operating Income -177.933.000 -101.864.000
74.7%
Pretax Income -162.337.000 -84.969.000
91.1%
Net Income Common Stockholders -162.337.000 -84.969.000
91.1%
-- --
--
-- --
--
ende